Wharton S Jelly Stem Cell Therapy

The use of stem cells in medicine has been at times a controversial therapy but the results of regenerative medicine can be dramatic.

Wharton s jelly stem cell therapy.

Diabetes mellitus dm is a devastating metabolic disease in which insulin secreting β cells in the islets. Mesenchymal stem cells which are the basis for a number of stem cell therapies and the relevant research may be limited in value when they have been collected from older patients. Wharton s jelly derived stem cells on the other hand appear to circumvent both of these problems making them valuable for a variety of applications in medicine. Wharton s jelly is considered immunologically privileged meaning the host s immune system is unable to detect.

Wharton s jelly stem cell therapy the moment when the first stem cell was discovered may have changed the medicine forever especially in terms of treatment of numerous and complicated conditions. Therapeutic potential of wharton s jelly mesenchymal stem cells for diabetes. Increasing numbers of both scientists and clinicians are interested in this tissue generally discarded at birth as a source of cells for therapy. Indeed wharton s jelly is among the simplest of human connective tissues and provides an apparently more homogeneous harvested cell population than other mesenchymal tissue sources.

The advantages of wharton s jelly therapy are twofold. Umbilical cord wharton s jelly as a potential source for stem cells. Patients who may have been struggling with joint pain and patients with cancers too would finally have therapies that gave better results. Achievements and challenges introduction.